Empowered Patient Podcast

Laura Mitchell, CEO, GrandCare has been working for many years to bring digital technology to the aging population and those facilities that are supporting senior housing communities. While remote sensing and telehealth have seen significant growth, COVID-19 has accelerated the need for family members, caregivers, and healthcare professionals to have remote access to seniors as well as the disabled. While necessity is the mother of invention, crisis may be the father of adoption.

@LauraHMitchell @GrandCare #GrandCare #COVID19 #telemedicine #telehealth #DigitalHealth

GrandCare.com

Listen to the podcast here

Laura Mitchell, CEO, GrandCare has been working for many years to bring digital technology to the aging population and those facilities that are supporting senior housing communities. While remote sensing and telehealth have seen significant growth, COVID-19 has accelerated the need for family members, caregivers, and healthcare professionals to have remote access to seniors as well as the disabled. While necessity is the mother of invention, crisis may be the father of adoption.

@LauraHMitchell @GrandCare #GrandCare #COVID19 #telemedicine #telehealth #digitalhealth

GrandCare.com

Download the transcript here

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients. Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their technology has strong anti-inflammatory benefits and keeps the cytokine release syndrome from a virus or other causes to a minimum. George also describes the origins of the discovery of the power of the nano-particles found in the amniotic fluid.

@OrganicellTM

#organicell #COVID19 #exosome #SARS #biotechnology

Organicell.com

Listen to the podcast here

Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients. Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their technology has strong anti-inflammatory benefits and keeps the cytokine release syndrome from a virus or other causes to a minimum. George also describes the origins of the discovery of the power of the nano-particles found in the amniotic fluid.

@OrganicellTM

#organicell #COVID19 #exosome #SARS #biotechnology

Organicell.com

Download the transcript here

Dr. Mark Erlander, CEO, Cardiff Oncology identifies the unmet needs of those suffering from metastatic colorectal cancer who have the oncogene KRAS mutation that hyper-drives the tumor growth. Mark talks about the company's investigational drug, onvansertib that is being evaluated in metastatic colorectal cancer (mCRC), acute myeloid leukemia (AML), and metastatic castrate-resistant prostate cancer (mCRPC). Onvansertib is a first-in-class, third-generation, oral and highly-selective inhibitor of PLK1, an enzyme that is over-expressed in most types of cancers. Onvansertib works synergistically in combination with approved chemotherapies and targeted therapeutics.

@CardiffOncology

#onvansertib #cancer #oncology #drugdevelopment #colorectalcancer #KRAS

Cardiffoncology.com

Listen to the podcast here

Dr. Mark Erlander, CEO, Cardiff Oncology identifies the unmet needs of those suffering from metastatic colorectal cancer who have the oncogene KRAS mutation that hyper-drives the tumor growth. Mark talks about the company's investigational drug, onvansertib that is being evaluated in metastatic colorectal cancer (mCRC), acute myeloid leukemia (AML), and metastatic castrate-resistant prostate cancer (mCRPC). Onvansertib is a first-in-class, third-generation, oral and highly-selective inhibitor of PLK1, an enzyme that is over-expressed in most types of cancers. Onvansertib works synergistically in combination with approved chemotherapies and targeted therapeutics.

@CardiffOncology

#onvansertib #cancer #oncology #drugdevelopment #colorectalcancer #KRAS

Cardiffoncology.com

Download the transcript here

Dr. Rachna Patel moved from a career as an emergency room doctor to become a medical marijuana doctor treating patients with a combination of cannabinoids like CBD and THC. She shares her insights about how the brain processes pain, how cannabinoids can reduce inflammation in the body, and how cannabinoids can impact the emotional processing of the pain. Dr. Patel also talks about the use of cannabis in conjunction with prescription pain medication to better manage symptoms. She is also the author of The CBD Oil Solution.

#cannabis #cannabinoids. #CBD #THC

DocPatels.com

Listen to the podcast here

Dr. Rachna Patel moved from a career as an emergency room doctor to become a medical marijuana doctor treating patients with a combination of cannabinoids like CBD and THC. She shares her insights about how the brain processes pain, how cannabinoids can reduce inflammation in the body, and how cannabinoids can impact the emotional processing of the pain. Dr. Patel also talks about the use of cannabis in conjunction with prescription pain medication to better manage symptoms. She is also the author of The CBD Oil Solution.

#cannabis #cannabinoids. #CBD #THC

DocPatels.com

Download the transcript here

Jeff Stein, President and CEO, Cidara Therapeutics talks about their antifungal platform rezafungin now in Phase 3 clinical development to address the needs of the vulnerable population of patients hospitalized for something else who get a life-threatening fungal infection in the hospital. Jeff also explains their Cloudbreak Antiviral Conjugates platform that is being used to target influenza and COVID-19. Cidara is not developing vaccines or monoclonal antibodies rather long-acting drugs that are virucidal and that recruit the immune system to clean up the infection. He also clearly describes the differences between fungi and viruses.

@CidaraThera @JeffStein

#coronavirus #COVID19 #influenza #fungalinfections #antifungal #antiviral

Cidara.com

Listen to the podcast here

Jeff Stein, President and CEO, Cidara Therapeutics talks about their antifungal platform rezafungin now in Phase 3 clinical development to address the needs of the vulnerable population of patients hospitalized for something else who get a life-threatening fungal infection in the hospital. Jeff also explains their Cloudbreak Antiviral Conjugates platform that is being used to target influenza and COVID-19. Cidara is not developing vaccines or monoclonal antibodies rather long-acting drugs that are virucidal and that recruit the immune system to clean up the infection. He also clearly describes the differences between fungi and viruses.

@CidaraThera @JeffStein

#coronavirus #COVID19 #influenza #fungalinfections #antifungal #antiviral

Cidara.com

Download the transcript